<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS137217</article-id>
<article-id pub-id-type="doi">10.1101/2021.10.16.463825</article-id>
<article-id pub-id-type="archive">PPR409017</article-id>
<article-version article-version-type="publisher-id">2</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>δ1 variant of SARS-COV-2 acquires spike V1176F and yields a highly mutated subvariant in Europe</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Xiang-Jiao</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Rosalind &amp; Morris Goodman Cancer Institute, McGill University, Montreal, Quebec H3A 1A3, Canada</aff>
<aff id="A2">
<label>2</label>Department of Medicine, McGill University, Montreal, Quebec H3A 1A3, Canada</aff>
<aff id="A3">
<label>3</label>Department of Biochemistry, McGill University, Montreal, Quebec H3A 1A3, Canada</aff>
<aff id="A4">
<label>4</label>Department of Medicine, McGill University Health Center, Montreal, Quebec H4A 3J1, Canada</aff>
<author-notes>
<corresp id="CR1">
<label>*</label>Corresponding contact: <email>xiang-jiao.yang@mcgill.ca</email>; Tel: 514-398-5883</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>21</day>
<month>10</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="preprint">
<day>19</day>
<month>10</month>
<year>2021</year>
</pub-date>
<permissions>
<ali:free_to_read/>
<license>
<ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">Genomic surveillance of SARS-COV-2 has revealed that in addition to many variants of interests, this virus has yielded four variants of concern, α, β, γ and δ, as designated by the World Health Organization. δ variant has recently become the predominant pandemic driver around the world and yielded four different subvariants (δ1, δ2, δ3 and δ4). Among them, δ1 has emerged as the key subvariant that drives the pandemic in India, Europe and the USA. A relevant question is whether δ1 subvariant continues to evolve and acquires additional mutations. Related to this, this subvariant has acquired spike V1176F, a signature substitution of γ variant, and yielded a new sublineage, δ1F. The substitution alters heptad repeat 2 of spike protein and is expected to improve interaction with heptad repeat 1 and enhance virus entry. Moreover, there are δ1F sublineages encoding spike N501Y, A783S, Q836E and V1264L. While N501Y is a signature substitution shared by α, β and γ variants, V1264L is a key substitution in a δ1 sublineage that is a major pandemic driver in Southeast Asia. The Q836E-encoding lineage carries an average of 50 mutations per genome, making it the most mutated variant identified so far. Similar to δ1 subvariant, δ2 subvariant has also acquired spike V1176F and yielded new sublineages. Together, these results suggest that V1176F is a recurrent spike substitution that is frequently acquired by SARS-COV-2 variants to improve viral fitness. It is thus important to track the evolutionary trajectory of related variants for considering and instituting the most effective public health measures.</p>
</abstract>
<kwd-group>
<kwd>Severe acute respiratory syndrome coronavirus</kwd>
<kwd>cell-cell fusion</kwd>
<kwd>B.1.1.7</kwd>
<kwd>B.1.351</kwd>
<kwd>P.1</kwd>
<kwd>B.1.617.2</kwd>
<kwd>A222V</kwd>
<kwd>R203M</kwd>
<kwd>L452R</kwd>
<kwd>T478K</kwd>
<kwd>phylogenetic analysis</kwd>
<kwd>mutation profiling</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p id="P2">Coronavirus disease 2019 (COVID-19) has caused the pandemic, led to tragic loss of life, overloaded health care systems and crippled the economy around the world. Just as this pandemic is unprecedented in the recent human history, global genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) is also unparalleled. As of October 16, 2021, almost 4.4 million SARS-COV-2 genomes have been sequenced and deposited into the GISAID (global initiative on sharing avian influenza data) genome sequence database [<xref ref-type="bibr" rid="R1">1</xref>]. This invaluable resource provides invaluable information and golden opportunities to track the evolutionary trajectory of the virus. Genomic surveillance of SARS-CoV-2 has firmly established that its evolution is the driving force of this pandemic. In addition to many variants of interests, the virus has yielded four variants of concern as designated by the WHO: α (B.1.1.7) [<xref ref-type="bibr" rid="R2">2</xref>], β (B.1.351) [<xref ref-type="bibr" rid="R3">3</xref>], γ (P.1) [<xref ref-type="bibr" rid="R4">4</xref>] and δ (B.1.617.2) [<xref ref-type="bibr" rid="R5">5</xref>]. One important question is what we can learn from known variants about the evolutionary trajectory of SARS-COV-2. Answers to this question will provide valuable scientific evidence for making informed decisions on the most effective public health measures, and help us identify potential future variants of concern.</p>
<p id="P3">To address this important question, I have tracked genomes in the GISAID database very closely. I have very recently found that δ variant has evolved further and yielded four subvariants (δ1, δ2, δ3 and δ4) in India [<xref ref-type="bibr" rid="R6">6</xref>]. Among them, δ1 has emerged as the major pandemic driver and δ2 plays a much less important role, whereas δ3 and δ4 have gradually faded away [<xref ref-type="bibr" rid="R6">6</xref>]. δ1 subvariant is also the major pandemic driver in Europe [<xref ref-type="bibr" rid="R6">6</xref>] and the USA [<xref ref-type="bibr" rid="R7">7</xref>]. These new findings raise a relevant question about whether δ1 subvariant continues to evolve and acquires additional mutations. Related to this question, I tried to determine whether SARS-COV-2 mutations show any conceptual analogy with germline mutations identified in genetic diseases and somatic mutations associated with cancer, because I have been working on these two types of mutations [<xref ref-type="bibr" rid="R8">8</xref>–<xref ref-type="bibr" rid="R10">10</xref>].</p>
<p id="P4">As a result, I realized and postulated that very similar to cancer mutations, SARS-COV-2 mutations are grouped into three large categories: driver, facilitator and passenger mutations. Different from passenger mutations, driver and facilitator mutations are recurrent. Recurrent frequency can sometimes help us distinguish between facilitator and passenger mutations. Notably, driver or facilitator mutations during SARS-COV-2 evolution are not so dominant as those identified in cancer. Still, some SARS-COV-2 mutations clearly act as drivers. One such example is D614G, a key substitution that has changed the entire course of the pandemic [<xref ref-type="bibr" rid="R11">11</xref>–<xref ref-type="bibr" rid="R13">13</xref>]. This substitution alters conformational state of the spike protein [<xref ref-type="bibr" rid="R14">14</xref>]. Another example is spike N501Y, shared by α [<xref ref-type="bibr" rid="R2">2</xref>], β [<xref ref-type="bibr" rid="R3">3</xref>] and γ [<xref ref-type="bibr" rid="R4">4</xref>] variants. This substitution enhances interaction with the cell-try receptor ACE2 [<xref ref-type="bibr" rid="R15">15</xref>]. A third example is spike P681R encoded by δ and κ variants [<xref ref-type="bibr" rid="R5">5</xref>]. It improves the furin cleavage site and confers evolutionary advantage [<xref ref-type="bibr" rid="R16">16</xref>]. With this hypothesis as a guide, I mapped the evolutionary trajectory of SARS-COV-2 evolution.</p>
<p id="P5">Among the four variants of concern, only γ variant encodes V1176F [<xref ref-type="bibr" rid="R4">4</xref>]. This substitution is located within heptad repeat 2 (HR2) of the S2 domain of spike protein and expected to improve interaction with HR1, which may facilitate virus entry to target cells by enhancing cell fusion potential [<xref ref-type="bibr" rid="R17">17</xref>]. This raises the question whether α [<xref ref-type="bibr" rid="R2">2</xref>], β [<xref ref-type="bibr" rid="R3">3</xref>] and δ [<xref ref-type="bibr" rid="R5">5</xref>] variants acquire V1176F during evolution. Here I describe that δ1 and δ2 subvariants have acquired spike V1176F and formed the new sublineages δ1F and δ2F, respectively (where the letter F denotes F1176). Moreover, δ1F has evolved further and acquired additional mutations, including spike N501Y, A783S, Q836E and V1264L. Alarmingly, the Q836E-encoding lineage, referred to as carries δ1F1, carries an average of 50 mutations per genome, thereby making it the most mutated SARS-COV-2 variant identified so far. Therefore, V1176F is recurrent and belongs to the facilitator or driver mutation category.</p>
</sec>
<sec id="S2" sec-type="results | discussion">
<title>Results and Discussion</title>
<sec id="S3">
<title>Spike V1176F is a recurrent substitution that may improve HR2 function</title>
<p id="P6">As shown in <xref ref-type="fig" rid="F1">Fig. 1A</xref>, spike protein is a multidomain protein composed of an N-terminal domain, a receptor-binding domain, a fusion peptide, a fusion peptide proximal region, heptad-repeat regions 1 and 2, a transmembrane motif and a C-terminal cytoplasmic tail. A recent study showed that the fusion peptide C-terminal proximal region is important for spike protein function (<xref ref-type="fig" rid="F1">Fig. 1A</xref>) [<xref ref-type="bibr" rid="R18">18</xref>]. V1176 is located within HR2 (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). HR2 is composed four heptad repeats and V1176 occupies a key position of repeat 1 (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). At the 3D structural level, V1176 is part of an unstructured loop. As four heptad repeats utilize key hydrophobic residues, such as V1176, for interaction with HR2 [<xref ref-type="bibr" rid="R17">17</xref>]. Because phenylalanine is much more hydrophobic than alanine, V1176F is expected to facilitate such interaction. This is also consistent that V1176F is a signature substitution in γ variant and its related variants, P.2 and P.3 [<xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R19">19</xref>]. As shown in <xref ref-type="fig" rid="F1">Fig. 1B</xref>, phenylalanine is also present at the equivalent position in the spike proteins from HKU1 and OC43. By contrast, a hydrophilic residue is present at the equivalent position in the spike proteins from NL63 and 229E, which is expected to make HR2 of these two coronaviruses less optimal. Thus, HR2 function is one potential avenue, on which SARS-COV-2 and related coronaviruses improves viral fitness.</p>
</sec>
<sec id="S4">
<title>Hundreds of V1176F-encoding δ genomes form distinct groups</title>
<p id="P7">Among the four <bold>v</bold>ariants of <bold>c</bold>oncern, only γ variant encodes V1176F [<xref ref-type="bibr" rid="R4">4</xref>]. In light of the potential importance of this substitution in improving viral fitness, I asked whether δ variant has also acquired this substitution. As a result, it was used it as a search criterion to identify δ genomes in the GISAID database. Indeed, this searched uncovered hundreds of δ genomes that encode V1176F as an extra substitution. Then I utilized Coronapp, an efficient web-based SARS-COV-2 mutation profiling application [<xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R21">21</xref>], to produce reports on mutations in 817 such V1176F-encoding δ genomes that were identified and sequenced in different countries around the world. The profiling results revealed that these genomes are mainly derivatives of δ1 and δ2 subvariants (with the corresponding sublineages referred to δ1F and δ2F, respectively, where the letter F denotes F1176; <xref ref-type="fig" rid="F2">Fig. 2</xref>), indicating that V1176F has been independently acquired. Intriguingly, a subset of genomes encode spike V1264L (<xref ref-type="fig" rid="F2">Fig. 2B</xref>), located at the cytoplasmic tail (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). This substitution is recurrent and may make δ1 and δ2 sublineages more virulent [<xref ref-type="bibr" rid="R22">22</xref>]. Another subset encodes spike Q836E (<xref ref-type="fig" rid="F2">Fig. 2B</xref>), located at the fusion peptide proximal region (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). Consistent with this heterogeneity, the distribution mutation load curve forms two distinct peaks, with the major peak carrying an average of 41 mutations per genome and the smaller peak centering at an average of 49-50 mutations per genome (<xref ref-type="fig" rid="F3">Fig. 3A</xref>). The mutation load from the major peak is expected from typical δ genomes identified in August and September 2021 [<xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R22">22</xref>], but the mutation load of the small peak is totally unexpected.</p>
<p id="P8">This raises an intriguing possibility that the small peak corresponds to V1264L- or Q836E-encoding δ genomes. Thus, these two types of genomes were identified and analyzed via Coronapp [<xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R21">21</xref>]. As shown in <xref ref-type="fig" rid="F3">Fig. 3B-C</xref>, V1264L-encoding δ genomes possess 42 mutations per genome, whereas Q836E-encoding δ genomes carry 50 mutations per genome. Thus, the small peak in <xref ref-type="fig" rid="F3">Fig. 3A</xref> is due to Q836E-encoding δ genomes. Manual inspection of the mutations revealed that these Q836E-encoding δ genomes are derivatives of δ1F subvariant, so the resulting sublineage is designated as δ1F1. Its mutation load at the average of ~50 mutations per genome makes δ1F1 the most mutated SARS-COV-2 lineage identified so far. In comparison, the mutation load is an average of 47 mutations per genome for C.1.2 variant, which has been reported to be the most mutated variant [<xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R24">24</xref>]. There are several δ1 sublineages carrying 46-49 mutations per genome [<xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R22">22</xref>].</p>
<p id="P9">Manual inspection of the mutations from V1264L-encoding δ genomes revealed that they are δ2F derivatives, supporting that V1176F has been acquired by two different δ subvariants. In agreement with this, phylogenetic analysis V1176F-encoding genomes identified two large groups corresponding to δ1F and δ2F (<xref ref-type="fig" rid="F3">Figs 3D</xref> &amp; <xref ref-type="supplementary-material" rid="SD2">S1</xref>). δ3 and δ4 subvariants have also acquired V1176F even though in terms of population size, the resulting sublineages are minor compared to those from δ1 and δ2 subvariants (<xref ref-type="fig" rid="F3">Figs 3D</xref> &amp; <xref ref-type="supplementary-material" rid="SD2">S1</xref>). Further phylogenetic analysis of V1264L-encoding δ genomes identified a major group encoding an extra spike substitution, P809S (<xref ref-type="fig" rid="F3">Figs 3E</xref> &amp; <xref ref-type="supplementary-material" rid="SD2">S2</xref>). These genomes were mainly identified in the USA (<xref ref-type="supplementary-material" rid="SD2">Fig. S1</xref>). Therefore, V1176F is recurrent and has been acquired by different δ subvariants.</p>
</sec>
<sec id="S5">
<title>Mutational analysis of δ1F1 as the most mutated SARS-COV-2 variant identified so far</title>
<p id="P10">Q836E-encoding δ-genomes were mainly identified in Europe (<xref ref-type="fig" rid="F3">Figs 3D</xref> &amp; <xref ref-type="supplementary-material" rid="SD2">S1</xref>). Mutational analysis of these genomes uncovered four silent mutations, F1107F of NSP3, S477S and Y707Y of spike protein, and S318S of nucleocapsid protein. Over 50% of the genomes also encode a fifth silent mutation, spike V991V. These five silent mutations contribute to the high mutation load of δ1F1 genomes and may have been subject to positive selection. Alternatively, they are just passenger mutations. However, silent mutations have been found to improve fitness of HIV-1 variants [<xref ref-type="bibr" rid="R25">25</xref>,<xref ref-type="bibr" rid="R26">26</xref>], so further investigation of the potential impact of these five silent mutations is warranted. In addition to the five silent mutations, spike A783S is encoded in over 20% of the genomes (<xref ref-type="fig" rid="F4">Fig. 4B</xref>). This substitution and V991V are mutually exclusive, so there are at least two subgroups within the group of Q836E-encoding δ-genomes. In support of this, phylogenetic analysis identified three subgroups, with two corresponding to the A783S-and V991V-encoding ones (<xref ref-type="fig" rid="F5">Fig. 5</xref>). Troublingly, inspection of the third subgroup identified one genome that encodes spike N501Y (<xref ref-type="fig" rid="F5">Figs 5</xref> &amp; <xref ref-type="supplementary-material" rid="SD2">S3</xref>). This signature substitution is shared by α [<xref ref-type="bibr" rid="R2">2</xref>], β [<xref ref-type="bibr" rid="R3">3</xref>] and γ [<xref ref-type="bibr" rid="R4">4</xref>] variants of concern, and known to improve ACE2 interaction [<xref ref-type="bibr" rid="R15">15</xref>]. Thus, δ1F1 has evolved further and acquired additional substitutions, including spike N501Y and A783S.</p>
</sec>
<sec id="S6">
<title>Mechanistic impact of different spike substitutions and a hypothetical model</title>
<p id="P11">As shown in <xref ref-type="fig" rid="F1">Fig. 1</xref>, V1176F is located within HR2 of spike protein and expected to improve interaction with HR1, which may in turn facilitate virus entry by enhancing cell fusion potential [<xref ref-type="bibr" rid="R17">17</xref>]. As illustrated in <xref ref-type="fig" rid="F1">Fig. 1</xref> &amp; <xref ref-type="fig" rid="F6">6A</xref>, P809 is only 6 residues away from the S2’ cleavage site. Structurally, this proline may hinder the cleavage (<xref ref-type="fig" rid="F6">Fig. 6B</xref>), so P809S may improve cleavage at this site. At the 3D structural level, A783 and Q836 are not far away from the cleavage site (<xref ref-type="fig" rid="F6">Fig. 6B-C</xref>). The side chain of Q836 is 3.5 Å away from D839 and may thus form a hydrogen bond (<xref ref-type="fig" rid="F6">Fig. 6B</xref>). A873 is in proximity to K786 (~5.1 Å), and both residues are on the same surface as the S2’ cleavage loop (<xref ref-type="fig" rid="F6">Fig. 6B</xref>). so A783S and Q836E may modulate the cleavage. Moreover, Q836 is located within a fusion peptide proximal region, which was recently found to be very important for spike protein function [<xref ref-type="bibr" rid="R18">18</xref>]. Thus, the S2’ cleavage site (<xref ref-type="fig" rid="F1">Figs 1A</xref> &amp; <xref ref-type="fig" rid="F6">6A-B</xref>) is a hot spot for SARS-COV-2 mutations to improve its viral fitness.</p>
<p id="P12">Four δ subvariants (δ1, δ2, δ3 and δ4) were initially identified in India [<xref ref-type="bibr" rid="R6">6</xref>] and then spread to the rest of the world [<xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R22">22</xref>]. Through convergent evolution, they have then acquired V1176F and yielded four sublineages (δ1F, δ2F, δ3F and δ4F; <xref ref-type="fig" rid="F3">Figs 3D</xref> &amp; <xref ref-type="fig" rid="F6">6D</xref>). Among them, δ1F is the fastest evolving and has acquired additional mutations. As for δ1F1 (<xref ref-type="fig" rid="F5">Fig. 5</xref>), its mutation load at the average of ~50 mutations per genome makes it the most mutated SARS-COV-2 variant identified so far. Alarmingly, one δ1F genome identified in September 2021 encodes N501Y (<xref ref-type="fig" rid="F5">Figs 5</xref> &amp; <xref ref-type="supplementary-material" rid="SD2">S3</xref>), a key spike substitution shared by α, β and γ variants of concern. Compared to δ1F, δ2F carries fewer mutations, but one subgroup encodes P809S (<xref ref-type="fig" rid="F3">Figs 3E</xref> &amp; <xref ref-type="fig" rid="F5">5</xref>), which is close to the S2’ cleavage site and may improve its cleavage efficiency. Thus, it will be important to track evolution of δ1F and δ2F in the coming few months. In summary, different δ subvariants have acquired spike V1176F and formed the new sublineages. Its importance and recurrent nature call for the need to annotate other substitutions located at the HR1 and HR2 regions of spike protein (<xref ref-type="fig" rid="F1">Fig. 1A</xref>).</p>
</sec>
</sec>
<sec id="S7" sec-type="materials | methods">
<title>Materials and Methods</title>
<sec id="S8">
<title>SARS-COV-2 genome sequences, mutational profiling and phylogenetic analysis</title>
<p id="P13">The genomes were downloaded the GISAID database on the dates specified in the figure legends. CoVsurver (<ext-link ext-link-type="uri" xlink:href="https://www.gisaid.org/epiflu-applications/covsurver-mutations-app/">https://www.gisaid.org/epiflu-applications/covsurver-mutations-app/</ext-link>) was used to analyze mutations on representative SARS-COV-2 genomes. Fasta files containing specific groups of genomes were downloaded from the GISAID database. During downloading, each empty space in the Fasta file headers was replaced by an underscore because such a space makes the files incompatible for subsequent mutational profiling, sequence alignment and phylogenetic analysis, as described with details in two other studies [<xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R24">24</xref>]. The Fasta headers were shortened and modified further as described [<xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R24">24</xref>]. The cleaned Fasta file was used for mutational profiling via Coronapp (<ext-link ext-link-type="uri" xlink:href="http://giorgilab.unibo.it/coronannotator/">http://giorgilab.unibo.it/coronannotator/</ext-link>), a web-based mutation annotation application [<xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R21">21</xref>]. The cleaned Fasta file was also uploaded onto SnapGene (version 5.3.2) for multisequence alignment via the MAFFT tool. RAxML-NG version 0.9.0 [<xref ref-type="bibr" rid="R27">27</xref>] was used for phylogenetic as described [<xref ref-type="bibr" rid="R6">6</xref>].</p>
</sec>
<sec id="S9">
<title>Defining different variant genomes using various markers</title>
<p id="P14">α, β, γ, δ and other variant genomes were downloaded from the GISAID database as defined by the server. δ subvariant genomes were defined as described [<xref ref-type="bibr" rid="R6">6</xref>]. Briefly, nucleocapsid substitutions G215C and R385K (Table 1) were used as markers for δ1 or δ3 genomes, respectively. Spike substitutions A222V and K77T were used as markers for δ2 or δ4 genomes, respectively. In Europe, there are many δ1V genomes that also encode spike A222V, so the NSP3 substitution P822L was used together with spike A222V to identify δ2 genomes. As discussed previously [<xref ref-type="bibr" rid="R6">6</xref>], there are several limitations with these markers. But they should not affect the overall conclusions.</p>
</sec>
<sec id="S10">
<title>PyMol structural modeling</title>
<p id="P15">The PyMol molecular graphics system (version 2.4.2, <ext-link ext-link-type="uri" xlink:href="https://pymol.org/2/">https://pymol.org/2/</ext-link>) from Schrodinger, Inc. was used for downloading structure files from the PDB database for further analysis and image generation. Structural images were cropped via Adobe Photoshop for further presentation through Illustrator.</p>
</sec>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Acknowledgement table on the GISAID genomes used in this study</label>
<media xlink:href="EMS137217-supplement-Acknowledgement_table_on_the_GISAID_genomes_used_in_this_study.pdf" mimetype="application" mime-subtype="pdf" id="N66343" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<label>Supplemental Information</label>
<media xlink:href="EMS137217-supplement-Supplemental_Information.pdf" mimetype="application" mime-subtype="pdf" id="N66352" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S11">
<title>Acknowledgement</title>
<p>I gratefully acknowledge the GISAID for diligent and tireless maintenance SARS-COV-2 genomes and numerous investigators for the valuable genome sequences used in this work (see the <xref ref-type="supplementary-material" rid="SD1">supplementary</xref> section for details). I am also grateful to Professor Federico M. Giorgi at University of Bologna, Italy, for developing Coronapp and generously allowing me timely access to the Coronapp server. This work was supported by funds from Canadian Institutes of Health Research (CIHR), Natural Sciences and Engineering Research Council of Canada (NSERC) and Compute Canada (to X.J.Y.).</p>
</ack>
<fn-group>
<fn id="FN1" fn-type="conflict">
<p id="P16">
<bold>Declaration of Interests</bold>
</p>
<p id="P17">The author declares no competing interests.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elbe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Buckland-Merrett</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Data, disease and diplomacy: GISAID’s innovative contribution to global health</article-title>
<source>Glob Chall</source>
<year>2017</year>
<volume>1</volume>
<fpage>33</fpage>
<lpage>46</lpage>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mishra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chand</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Barrett</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Geidelberg</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hinsley</surname>
<given-names>WR</given-names>
</name>
<name>
<surname>Laydon</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Dabrera</surname>
<given-names>G</given-names>
</name>
<name>
<surname>O’Toole</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Amato</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England</article-title>
<source>Nature</source>
<year>2021</year>
<comment>epub</comment>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tegally</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Giovanetti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Iranzadeh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fonseca</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Giandhari</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Doolabh</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pillay</surname>
<given-names>S</given-names>
</name>
<name>
<surname>San</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Msomi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mlisana</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>Detection of a SARS-CoV-2 variant of concern in South Africa</article-title>
<source>Nature</source>
<year>2021</year>
<volume>592</volume>
<fpage>438</fpage>
<lpage>443</lpage>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faria</surname>
<given-names>NR</given-names>
</name>
<etal/>
</person-group>
<article-title>Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil</article-title>
<source>Science</source>
<year>2021</year>
<volume>372</volume>
<fpage>815</fpage>
<lpage>821</lpage>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mlcochova</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion</article-title>
<source>Nature</source>
<year>2021</year>
<comment>Epub</comment>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>XJ</given-names>
</name>
</person-group>
<article-title>SARS-COV-2 delta variant drives the pandemic in India and Europe through two subvariants</article-title>
<source>medRxiv (submitted)</source>
<year>2021</year>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>XJ</given-names>
</name>
</person-group>
<article-title>SARS-COV-2 delta variant drives the pandemic in the USA through two subvariants</article-title>
<source>Research Square</source>
<year>2021</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://www.researchsquare.com/article/rs-986605/v1">https://www.researchsquare.com/article/rs-986605/v1</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rousseau</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Littlejohn</surname>
<given-names>RO</given-names>
</name>
<name>
<surname>Kiss</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lehman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Stumpel</surname>
<given-names>CTR</given-names>
</name>
<name>
<surname>Stegmann</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Robak</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Scaglia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>TT</given-names>
</name>
<etal/>
</person-group>
<article-title>Mutations in the chromatin regulator gene BRPF1 causes syndromic intellectual disability and deficient histone acetylation</article-title>
<source>Am J Hum Genet</source>
<year>2017</year>
<volume>100</volume>
<fpage>91</fpage>
<lpage>104</lpage>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rousseau</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Machol</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Agre</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Goverde</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Engleman</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Verdin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Baere</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Potocki</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>Deficient histone H3 propionylation by BRPF1-KAT6 complexes in neurodevelopmental disorders and cancer</article-title>
<source>Sci Adv</source>
<year>2020</year>
<volume>6</volume>
<elocation-id>eaax0021</elocation-id>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ghorbani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hubshman</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Rousseau</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Thiffault</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Schnur</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Breen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Oegema</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Waisfisz</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Welner</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Lysine acetyltransferase 8 is involved in cerebral development and syndromic intellectual disability</article-title>
<source>J Clin Investig</source>
<year>2020</year>
<volume>130</volume>
<fpage>1431</fpage>
<lpage>1445</lpage>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plante</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Lokugamage</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Muruato</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fontes-Garfias</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Mirchandani</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility</article-title>
<source>bioRxiv</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>Plante</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lokugamage</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Muruato</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fontes-Garfias</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mirchandani</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility</article-title>
<source>Res Sq</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plante</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Lokugamage</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Muruato</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fontes-Garfias</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Mirchandani</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Spike mutation D614G alters SARS-CoV-2 fitness</article-title>
<source>Nature</source>
<year>2021</year>
<volume>592</volume>
<fpage>116</fpage>
<lpage>121</lpage>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sterling</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>RM</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Rawson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rits-Volloch</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Distinct conformational states of SARS-CoV-2 spike protein</article-title>
<source>Science</source>
<year>2020</year>
<volume>369</volume>
<fpage>1586</fpage>
<lpage>1592</lpage>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Starr</surname>
<given-names>TN</given-names>
</name>
<name>
<surname>Greaney</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Hilton</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>KHD</given-names>
</name>
<name>
<surname>Dingens</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Navarro</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Bowen</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Tortorici</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Walls</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>King</surname>
<given-names>NP</given-names>
</name>
<etal/>
</person-group>
<article-title>Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding</article-title>
<source>Cell</source>
<year>2020</year>
<volume>182</volume>
<fpage>1295</fpage>
<lpage>1310</lpage>
<elocation-id>e20</elocation-id>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>XJ</given-names>
</name>
</person-group>
<article-title>SARS-COV-2 gamma variant acquires spike P681H or P681R for improved viral fitness</article-title>
<source>bioRxiv</source>
<year>2021</year>
<pub-id pub-id-type="doi">10.1101/2021.10.16.464641v1</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Escalante</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Farmar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Debnath</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Tien</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors</article-title>
<source>Lancet</source>
<year>2004</year>
<volume>363</volume>
<fpage>938</fpage>
<lpage>47</lpage>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lavine</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Rawson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Anand</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gautam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants</article-title>
<source>Science</source>
<year>2021</year>
<volume>373</volume>
<fpage>642</fpage>
<lpage>648</lpage>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tablizo</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Lapid</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Castro</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Yangzon</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Maralit</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Ayes</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Cutiongco-de la Paz</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>De Guzman</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Yap</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Salvaña</surname>
<given-names>EM</given-names>
</name>
<etal/>
</person-group>
<article-title>Genome sequencing and analysis of an emergent SARS-CoV-2 variant characterized by multiple spike protein mutations detected from the Central Visayas Region of the Philippines</article-title>
<source>bioRxiv</source>
<year>2021</year>
<pub-id pub-id-type="doi">10.1101/2021.03.03.21252812</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mercatelli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Triboli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fornasari</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Giorgi</surname>
<given-names>FM</given-names>
</name>
</person-group>
<article-title>Coronapp: A web application to annotate and monitor SARS-CoV-2mutations</article-title>
<source>J Med Virol</source>
<year>2021</year>
<volume>93</volume>
<elocation-id>32383245</elocation-id>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mercatelli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Giorgi</surname>
<given-names>FM</given-names>
</name>
</person-group>
<article-title>Geographic and Genomic Distribution of SARS-COV-2 Mutations</article-title>
<source>Front Microbiol</source>
<year>2020</year>
<volume>11</volume>
<fpage>1800</fpage>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>XJ</given-names>
</name>
</person-group>
<article-title>Delta-1 variant of SARS-COV-2 acquires spike V1264L and drives the pandemic in Indonesia, Singapore and Malaysia</article-title>
<source>Research Square (submitted)</source>
<year>2021</year>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheepers</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Everatt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Amoako</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Mnguni</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ismail</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mahlangu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wibmer</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tegally</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Emmanuel San</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Giandhari</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>The continuous evolution of SARS-CoV-2 in South Africa: a new lineage with rapid accumulation of mutations of concern and global detection</article-title>
<source>medRxiv</source>
<year>2021</year>
<pub-id pub-id-type="doi">10.1101/2021.08.20.21262342v1.full</pub-id>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>XJ</given-names>
</name>
</person-group>
<article-title>SARS-COV-2 C.1.2 variant is highly mutated but may exhibit reduced affinity for ACE2 receptor</article-title>
<source>bioRxiv</source>
<year>2021</year>
<pub-id pub-id-type="doi">10.1101/2021.10.16.464644v1</pub-id>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harrigan</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Sheen</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Wynhoven</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lima</surname>
<given-names>VD</given-names>
</name>
<name>
<surname>Lecocq</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Aguirre</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Poon</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Sluis-Cremer</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Silent mutations are selected in HIV-1 reverse transcriptase and affect enzymatic efficiency</article-title>
<source>AIDS</source>
<year>2008</year>
<volume>22</volume>
<fpage>2501</fpage>
<lpage>8</lpage>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Telwatte</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hearps</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Latham</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Agius</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tachedjian</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sonza</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sluis-Cremer</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Harrigan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tachedjian</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>Silent mutations at codons 65 and 66 in reverse transcriptase alleviate indel formation and restore fitness in subtype B HIV-1 containing D67N and K70R drug resistance mutations</article-title>
<source>Nucleic Acids Res</source>
<year>2015</year>
<volume>43</volume>
<fpage>3256</fpage>
<lpage>71</lpage>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kozlov</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Darriba</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Flouri</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Morel</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Stamatakis</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>RAxML-NG: a fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference</article-title>
<source>Bioinformatics</source>
<year>2019</year>
<volume>35</volume>
<fpage>4453</fpage>
<lpage>4455</lpage>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>XJ</given-names>
</name>
</person-group>
<article-title>Delta-1 variant of SARS-COV-2 acquires spike V1176F and yields a highly mutated subvariant in Europe</article-title>
<source>bioRxiv</source>
<year>2021</year>
<pub-id pub-id-type="doi">10.1101/2021.10.16.463825v1</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<title>Spike V1176F alters heptad repeat 2.</title>
<p>(<bold>A</bold>) Domain organization of spike protein. Some key substitutions are shown in black and new substitutions to be described herein are in red. NTD, N-terminal domain; RBD, receptor-binding domain; S1/S2, boundary of S1 and S2 domains after furin cleavage between residues R685 and S686; FP, fusion peptide; FPR, fusion peptide proximal region; HR1 and HR2, heptad-repeat regions 1 and 2, respectively; S2’, cleavage site between residues R815 and S816 in S2 domain; TM, transmembrane motif; CT, C-terminal cytoplasmic tail. The domain organization was adapted from a published study [<xref ref-type="bibr" rid="R18">18</xref>]. (<bold>B</bold>) Sequence alignment of spike proteins from SARS-COV-2 and five other coronaviruses. For simplicity, only heptad repeat 2 and the transmembrane domain are shown. Positions of key hydrophobic residues defining the four heptad repeats are indicated at the top. V1176 is a key residue in HR2 and V1176F may make the domain more optimal for interaction with HR1. Phenylalanine is also present at the equivalent position in the spike proteins from HKU1 and OC43. By contrast, a hydrophilic residue is present at the equivalent position in the spike proteins from NL63 and 229E. (<bold>C</bold>) Structure around V1176 of spike protein. The S2 domain of the protein form a trimer. For simplicity, only the hexa-helix bundle formed by HR1 and HR2 is shown here. HR1 occupies the core of the bundle whereas HR2 is at the out-skirt. The region from A1174 and I1179 of HR2 could not be defined structurally (depicted with dashed lines) and may be unstructured, so only an approximate position of V1176 is indicated. It is close to V951, V952 and A956 of HR1, so V1176F may enhance hydrophobic interaction with these three residues. Based on PyMol presentation of 6XRA from the PDB database.</p>
</caption>
<graphic xlink:href="EMS137217-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>Mutation profile of 817 V1176F-encoding δ genomes from different countries around the world. The genomes were downloaded from the GISAID SARS-COV-2 genome sequence database on September 24, 2021 for mutation profiling via Coronapp [<xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R21">21</xref>]. Shown in (A), (B) and (C) are substitutions in NSP3, spike and nucleocapsid proteins, respectively.</p>
</caption>
<graphic xlink:href="EMS137217-f002"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<title>Mutation load and phylogenetic relationship of different δ subvariants.</title>
<p>(<bold>A-C</bold>) Mutation load of three different groups of δ genomes. The distribution was generated via Coronapp. The genomes were downloaded from the GISAID database on September 24, 2021 for mutation profiling via Coronapp [<xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R21">21</xref>]. <bold>(B)</bold> Phylogenetic analysis of the 182 V1176-encoding δ genomes identified by June 15, 2021. Only those with high sequence coverage and complete collection date information were used for phylogenetic analysis via the package RAxML-NG, to generate 20 maximum likelihood trees and one bestTree for presentation via FigTree. The strain names and GISAID accession numbers of the genomes are provided in <xref ref-type="supplementary-material" rid="SD2">Figure S1</xref>. <bold>(E)</bold> Phylogenetic analysis of the 97 V1176F- and V1264L-encoding δ-genomes. The analysis was done as in (D). The strain names and GISAID accession numbers of the genomes are provided in <xref ref-type="supplementary-material" rid="SD2">Figure S2</xref>. The genomes used in panels D-E were downloaded from the GISAID database on September 24, 2021</p>
</caption>
<graphic xlink:href="EMS137217-f003"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<p>Mutation profile of 145 V1176F- and Q836E-encoding δ genomes identified and sequenced in different countries around the world. The genomes were downloaded from the GISAID SARS-COV-2 genome sequence database on September 24, 2021 for mutation profiling via Coronapp. Shown in (A), (B) and (C) are substitutions in NSP3, spike and nucleocapsid proteins, respectively.</p>
</caption>
<graphic xlink:href="EMS137217-f004"/>
</fig>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption>
<p>Phylogenetic analysis of the 143 Q836E-encoding δ genomes. The genomes are the same those used in <xref ref-type="fig" rid="F4">Fig. 4</xref> except two low-coverage genomes were excluded. The phylogenetic analysis was carried out as in <xref ref-type="fig" rid="F3">Fig. 3D</xref>. The strain names and GISAID accession numbers of the genomes are provided in <xref ref-type="supplementary-material" rid="SD2">Figure S3</xref>.</p>
</caption>
<graphic xlink:href="EMS137217-f005"/>
</fig>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption>
<title>Mechanistic impact of spike substitutions and an evolutionary model.</title>
<p>(<bold>A</bold>) Sequence comparison of the S2’ cleavage site of SARS-COV-2 spike protein with the corresponding regions of spike proteins from five other beta coronaviruses, SARS-COV-1, HKU1, NL63, 229E and OC43. The P809S substitution and the S2’ cleavage site are indicated above the SARS-COV-2 spike protein sequence. (<bold>B-C</bold>) Structural details showing spike P809, Q836E and their neighboring residues. All of them are on the surface containing the S1/S2 and S2’ cleavage sites. P809 is close the S2’ cleavage site between R815 and S816 (B). This site is only about 40 Å away from T676, which is N-terminal to the unstructured S1/S2 cleave loop. The side chain of Q836 is 3.5 Å away from D839 and may thus form a hydrogen bond (B). A873 is proximity to K786 (~5.1 Å), and both residues are in the same surface as the S2’ cleavage loop (C). Adapted from PyMol presentation of the spike protein-ACE2 complex structure 6XR8 from the PDB database. (<bold>D</bold>) Hypothetical model explaining how different substitutions are acquired during generation of different variants and subvariants. There are four δ subvariants (δ1, δ2, δ3 and δ4) initially identified in India. Through convergent evolution, they have then acquired V1176F and yielded four δ subvariants (δ1F, δ2F, δ3F and δ4F). Alarmingly, one δ1F genome recently identified in Czech Republic encodes N501Y, a key spike substitution shared by α, β and γ variants of concern. This continuous branching model is similar to what has been presented in several related studies [<xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R16">16</xref>,<xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R28">28</xref>].</p>
</caption>
<graphic xlink:href="EMS137217-f006"/>
</fig>
</floats-group>
</article>
